Today: 9 June 2026
Upwork stock drops 3% today as UPWK slips below $20 with earnings ahead
30 December 2025
2 mins read

Upwork stock drops 3% today as UPWK slips below $20 with earnings ahead

NEW YORK, December 30, 2025, 15:28 ET — Regular session

  • UPWK underperformed a muted U.S. stock market into the final trading days of 2025.
  • Investors are looking to the next quarterly report for updates on growth, margins and AI-led products.
  • Gig-economy and online hiring peers were mixed in afternoon trade.

Upwork Inc shares were last down 3.4% at $19.60 on Tuesday, after dipping as low as $19.60 in the session. The stock, valued at about $2.46 billion, was sliding even as the S&P 500 and Nasdaq-100 proxies were only modestly lower.

The move matters because Upwork has been trading as a profitability-and-execution story, leaving the stock prone to sharp swings when investors rotate away from smaller growth names. A fall below the $20 level also puts a spotlight on near-term technical support, with traders watching whether the stock can reclaim its prior close.

The next major catalyst is Upwork’s next earnings report, which Nasdaq’s earnings calendar estimates for February 11. Investors will be looking for updates on client activity, platform spending and whether management can keep margins expanding into 2026.

Upwork’s latest formal update came with its third-quarter results on November 3, when it reported revenue of $201.7 million and GAAP net income of $29.3 million and said gross services volume (GSV) — a measure of client spending on its platform — rose 2% from a year earlier. The company guided fourth-quarter revenue of $193 million to $198 million and non-GAAP diluted EPS of $0.31 to $0.33, and raised full-year revenue and adjusted EBITDA targets; adjusted EBITDA is a profit metric that strips out some expenses and non-cash items. “We crossed the $200 million revenue milestone,” CFO Erica Gessert said in the release, which also highlighted faster growth in AI-related projects and an enterprise push tied to its Lifted unit. SEC

GSV is closely tracked by investors because it can signal whether demand is rising or falling on the marketplace before that flow shows up in reported revenue. “Non-GAAP” figures exclude certain items and are commonly used by management teams and analysts to compare operating performance across periods.

Upwork operates an online marketplace that connects businesses with freelance talent, and its results can be sensitive to shifts in hiring plans and discretionary project budgets. That makes the stock a frequent read-through on broader labor-market sentiment, especially for tech and services clients.

Competition in online freelance and hiring platforms remains intense, with Upwork facing rivals that range from freelancer marketplaces to job boards and enterprise staffing solutions. Investors often compare product innovation and customer retention across the group when earnings season approaches.

In the near term, traders are also watching whether Upwork can stabilize after Tuesday’s slide to the session low and whether buyers step in around psychological levels such as $20. A quick bounce can signal that selling pressure is fading; a failure to hold recent lows can keep momentum tilted toward sellers.

Before the next earnings update, investors are likely to focus on signs that AI-related work continues to gain share on the platform, that enterprise initiatives translate into customer adoption, and that profitability holds up even if growth remains uneven. Broader market risk appetite into early 2026 will also influence smaller tech names such as Upwork.

Stock Market Today

  • Jim Cramer's Top 10 Market Watch Points for June 9
    June 9, 2026, 9:57 AM EDT. Jim Cramer's top 10 things to watch on June 9 include U.S. stocks rebounding after a selloff, supported by lower oil prices and bond yields. The SpaceX IPO is heavily oversubscribed, expected to start trading Friday, while OpenAI filed confidentially for its IPO with a potential trillion-dollar valuation. Anthropic secured a $35 billion debt deal to fund its AI growth. TD Cowen raised its Alphabet price target to $475 amid margin optimism, despite dilution concerns. Amazon issued a $10 billion Canadian dollar bond, the largest in that currency. China plans to invest $295 billion in AI data centers over five years. Micron is expected to beat earnings guidance, while Apple shares face pressure despite AI enhancements. GSK's $10.6 billion acquisition of Nuvalent lifts shares, highlighting moves in the healthcare sector.

Latest articles

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

9 June 2026
IREN surged 8.9% to $59.19 and was quoted higher premarket after a bitcoin rebound and renewed focus on its pivot to AI cloud infrastructure, but the stock remains exposed to bitcoin swings, heavy spending, and risks tied to its new 800MW South Australia data center project and major contracts with Nvidia and Microsoft.
AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

9 June 2026
AT&T shares edged up to $22.58 pre-market after reaffirming 2026 guidance and a $45B+ shareholder return plan, providing a cash-flow marker as satellite broadband competition looms; the stock remains pressured by SpaceX risks flagged by Oppenheimer, with second-quarter free cash flow seen at $4.0–$4.5B.
GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
SELLAS Life Sciences (SLS) stock jumps on Phase 3 AML trial timing update — what investors watch next
Previous Story

SELLAS Life Sciences (SLS) stock jumps on Phase 3 AML trial timing update — what investors watch next

Newmont stock rebounds as gold steadies after CME margin jolt; Raymond James lifts target
Next Story

Newmont stock rebounds as gold steadies after CME margin jolt; Raymond James lifts target

Go toTop